Letter sent to Healthcare Professionals: Belvo (valproate semisodium) 250 mg gastro-resistant tablets

Letter advises that the MHRA has approved the extension of the shelf life of two batches (batch number 19FQ052 and 19FQ053) from June 2020 to the end of December 2020.

Consilient Health Ltd